Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer.

Qu D, Weygant N, Yao J, Chandrakesan P, Berry WL, May R, Pitts K, Husain S, Lightfoot S, Li M, Wang TC, An G, Clendenin C, Stanger BZ, Houchen CW.

J Oncol. 2019 Aug 5;2019:6402925. doi: 10.1155/2019/6402925. eCollection 2019.

2.

Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma.

Cao J, Pickup S, Clendenin C, Blouw B, Choi H, Kang D, Rosen M, O'Dwyer PJ, Zhou R.

Clin Cancer Res. 2019 Apr 1;25(7):2314-2322. doi: 10.1158/1078-0432.CCR-18-2276. Epub 2018 Dec 26.

PMID:
30587546
3.

Unique pattern of neutrophil migration and function during tumor progression.

Patel S, Fu S, Mastio J, Dominguez GA, Purohit A, Kossenkov A, Lin C, Alicea-Torres K, Sehgal M, Nefedova Y, Zhou J, Languino LR, Clendenin C, Vonderheide RH, Mulligan C, Nam B, Hockstein N, Masters G, Guarino M, Schug ZT, Altieri DC, Gabrilovich DI.

Nat Immunol. 2018 Nov;19(11):1236-1247. doi: 10.1038/s41590-018-0229-5. Epub 2018 Oct 15.

4.

Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.

Lo A, Wang LS, Scholler J, Monslow J, Avery D, Newick K, O'Brien S, Evans RA, Bajor DJ, Clendenin C, Durham AC, Buza EL, Vonderheide RH, June CH, Albelda SM, Puré E.

Cancer Res. 2015 Jul 15;75(14):2800-2810. doi: 10.1158/0008-5472.CAN-14-3041. Epub 2015 May 15.

5.

Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.

Beatty GL, Winograd R, Evans RA, Long KB, Luque SL, Lee JW, Clendenin C, Gladney WL, Knoblock DM, Guirnalda PD, Vonderheide RH.

Gastroenterology. 2015 Jul;149(1):201-10. doi: 10.1053/j.gastro.2015.04.010. Epub 2015 Apr 14.

6.

Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.

Winograd R, Byrne KT, Evans RA, Odorizzi PM, Meyer AR, Bajor DL, Clendenin C, Stanger BZ, Furth EE, Wherry EJ, Vonderheide RH.

Cancer Immunol Res. 2015 Apr;3(4):399-411. doi: 10.1158/2326-6066.CIR-14-0215. Epub 2015 Feb 12.

7.

A common pathway for dendritic cell and early B cell development.

Izon D, Rudd K, DeMuth W, Pear WS, Clendenin C, Lindsley RC, Allman D.

J Immunol. 2001 Aug 1;167(3):1387-92.

8.

Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells.

Strobeck M, Kim S, Zhang JC, Clendenin C, Du KL, Parmacek MS.

J Biol Chem. 2001 May 11;276(19):16418-24. Epub 2001 Feb 8.

9.

Mop3 is an essential component of the master circadian pacemaker in mammals.

Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS, Bradfield CA.

Cell. 2000 Dec 22;103(7):1009-17.

10.

A minimal c-fes cassette directs myeloid-specific expression in transgenic mice.

Heydemann A, Warming S, Clendenin C, Sigrist K, Hjorth JP, Simon MC.

Blood. 2000 Nov 1;96(9):3040-8.

11.

A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2.

Svensson EC, Huggins GS, Lin H, Clendenin C, Jiang F, Tufts R, Dardik FB, Leiden JM.

Nat Genet. 2000 Jul;25(3):353-6.

PMID:
10888889
12.

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.

Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, McNally EM.

J Cell Biol. 1998 Sep 7;142(5):1279-87.

13.

Eye care utilisation patterns in a rural county in Ireland: implications for service delivery.

Clendenin C, Coffey M, Marsh M, West S.

Br J Ophthalmol. 1997 Nov;81(11):972-5.

14.

The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis.

Kuo CT, Veselits ML, Barton KP, Lu MM, Clendenin C, Leiden JM.

Genes Dev. 1997 Nov 15;11(22):2996-3006.

15.
16.

Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB.

Barton K, Muthusamy N, Chanyangam M, Fischer C, Clendenin C, Leiden JM.

Nature. 1996 Jan 4;379(6560):81-5.

PMID:
8538746

Supplemental Content

Loading ...
Support Center